Abingdon Health Plc (AIM:ABDX)
London
· Delayed Price · Currency is GBP · Price in GBX 6.75
0.00 (0.00%)
At close: Dec 5, 2025
Abingdon Health Income Statement
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2018 |
| Revenue | 8.43 | 6.14 | 4.05 | 2.84 | 11.62 | Upgrade
|
| Revenue Growth (YoY) | 37.39% | 51.67% | 42.68% | -75.60% | 121.93% | Upgrade
|
| Cost of Revenue | 4.69 | 2.46 | 1.97 | 6.43 | 7.48 | Upgrade
|
| Gross Profit | 3.74 | 3.68 | 2.08 | -3.59 | 4.14 | Upgrade
|
| Selling, General & Admin | 7.71 | 5.07 | 5.22 | 6.65 | 7.55 | Upgrade
|
| Amortization of Goodwill & Intangibles | 0.11 | 0.03 | 0.03 | 0.12 | 0.04 | Upgrade
|
| Other Operating Expenses | -0.47 | -0.26 | -0.25 | -0.24 | -0.15 | Upgrade
|
| Operating Expenses | 8.07 | 5.29 | 5.69 | 8.27 | 9.52 | Upgrade
|
| Operating Income | -4.33 | -1.61 | -3.61 | -11.87 | -5.37 | Upgrade
|
| Interest Expense | -0.09 | -0.05 | -0.07 | -0.07 | -0.23 | Upgrade
|
| Interest & Investment Income | 0.1 | 0.03 | 0.09 | 0 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.45 | -0 | 0.39 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -3.87 | -1.63 | -3.21 | -11.93 | -5.61 | Upgrade
|
| Merger & Restructuring Charges | - | - | -0.16 | -0.2 | -0.19 | Upgrade
|
| Impairment of Goodwill | - | - | - | -0.76 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.01 | - | - | - | - | Upgrade
|
| Asset Writedown | 0.14 | - | -0.09 | -6.43 | - | Upgrade
|
| Legal Settlements | - | - | - | -1.59 | - | Upgrade
|
| Other Unusual Items | 0.23 | 0.23 | -0.12 | -0.69 | -1.16 | Upgrade
|
| Pretax Income | -3.5 | -1.4 | -3.57 | -21.59 | -6.95 | Upgrade
|
| Income Tax Expense | -0.08 | -0.13 | -0.11 | -0.33 | 0.02 | Upgrade
|
| Net Income | -3.42 | -1.27 | -3.47 | -21.26 | -6.97 | Upgrade
|
| Net Income to Common | -3.42 | -1.27 | -3.47 | -21.26 | -6.97 | Upgrade
|
| Shares Outstanding (Basic) | 367 | 305 | 304 | 292 | 278 | Upgrade
|
| Shares Outstanding (Diluted) | 367 | 305 | 304 | 292 | 278 | Upgrade
|
| Shares Change (YoY) | 20.32% | 0.23% | 4.26% | 4.89% | - | Upgrade
|
| EPS (Basic) | -0.01 | -0.00 | -0.01 | -0.07 | -0.03 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.00 | -0.01 | -0.07 | -0.03 | Upgrade
|
| Free Cash Flow | -3.51 | -1.69 | 0.84 | -8.42 | -19.64 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | 0.00 | -0.03 | -0.07 | Upgrade
|
| Gross Margin | 44.32% | 59.97% | 51.30% | -126.70% | 35.66% | Upgrade
|
| Operating Margin | -51.38% | -26.18% | -89.27% | -418.52% | -46.24% | Upgrade
|
| Profit Margin | -40.52% | -20.72% | -85.76% | -749.98% | -60.02% | Upgrade
|
| Free Cash Flow Margin | -41.63% | -27.61% | 20.72% | -297.04% | -169.02% | Upgrade
|
| EBITDA | -3.72 | -1.25 | -2.98 | -10.59 | -4.94 | Upgrade
|
| EBITDA Margin | -44.17% | -20.36% | -73.75% | - | -42.54% | Upgrade
|
| D&A For EBITDA | 0.61 | 0.36 | 0.63 | 1.28 | 0.43 | Upgrade
|
| EBIT | -4.33 | -1.61 | -3.61 | -11.87 | -5.37 | Upgrade
|
| EBIT Margin | -51.38% | -26.18% | -89.27% | - | -46.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.